TET2 mutations are abundant in hematopoietic malignancies, and cardiovascular diseases (Ferrone et al., 2020), as well as in increased inflammatory macrophage activation in TET2 knockouts (Fuster et al., 2017). Here, TET2 is linked to cardiovascular disorder.